Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Protagonist Therapeutics (PTGX) Interest Expenses (2020)

Protagonist Therapeutics' Interest Expenses history spans 1 years, with the latest figure at $127000.0 for Q4 2020.

  • For Q4 2020, Interest Expenses changed N/A year-over-year to $127000.0; the TTM value through Sep 2021 reached $127000.0, down 73.04%, while the annual FY2020 figure was $598000.0, 253.85% up from the prior year.
  • Interest Expenses for Q4 2020 was $127000.0 at Protagonist Therapeutics, up from $19000.0 in the prior quarter.
  • Across five years, Interest Expenses topped out at $243000.0 in Q1 2020 and bottomed at $19000.0 in Q3 2020.